Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Therapeutic Advances in Vaccines and Immunotherapy is Scopus-indexed (Q1, CiteScore 6), DOAJ. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2515-1355Verify ISSN ↗2515-1363Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 64 / 278 | 77th | Q1 |
| Oncology | 109 / 428 | 74th | Q2 |
| Immunology and Allergy | 86 / 234 | 63rd | Q2 |
| Drug Discovery | 60 / 161 | 63rd | Q2 |
| Immunology | 94 / 243 | 61st | Q2 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q1, CiteScore 6.
Therapeutic Advances in Vaccines and Immunotherapy is Q1 in Pharmacology (medical) (rank 64 of 278), Q2 in Oncology (rank 109 of 428) and Q2 in Immunology and Allergy (rank 86 of 234), by CiteScore 2025. It is ranked in 5 subject areas in all.
Therapeutic Advances in Vaccines and Immunotherapy is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 6, quartile Q1, 77th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.832, quartile Q2, with an H-index of 20.
Therapeutic Advances in Vaccines and Immunotherapy is published by SAGE Publications Ltd. Its print ISSN is 2515-1355 and its online ISSN is 2515-1363.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Therapeutic Advances in Vaccines and Immunotherapy has an h-index of 23 and a 2-year mean of 4.89 citations per paper (OpenAlex). Its Scopus CiteScore is 6, quartile Q1. On 2-year citations it ranks #28 of 271 Scopus journals in Pharmacology (medical).
Therapeutic Advances in Vaccines and Immunotherapy published 22 papers in 2025; its busiest recent year was 2024 with 27. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2021–2026), authors are most often from United States (14.8%), India (12.7%) and Philippines (11.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (14.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.